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deviations was related to the beam energy, i.e. larger deviations were 
observed for the higher beam energy. The overall treatment time 
calculated with superposition was 5-7 % longer in comparison to the 
calculation of convolution, and the coverage of PTV, in terms of 95% 
isodose, was better (up to 18%). Hot spots were lower for 
superposition plans for both low and high energies. 
Conclusions: Convolution algorithms are not adequate for dose 
calculations in the presence of and inside low density 
inhomogeneities, while the superposition algorithm showed better 
agreement for all cases.Convolution algorithm overestimates the 
delivered dose, which leads to the underdosage of the target volume 
in reality. This applies both to lower energy and even more to higher 
energy beams. Differences between doses calculated with 
superposition and convolution algorithms are primarily due to changes 
in electron transport in the lungs, which is not adequately taken into 
account by convolution algorithm. Following these findings, and 
recommendations from the literature all lung patients is planned with 
superposition algorithm. 
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Purpose/Objective: To evaluate the effect of 6, 15 MV and mixed 
energy (6&15MV) on intensity-modulated radiation therapy (IMRT) 
plans for prostate cancer using the equivalent uniform dose (EUD) and 
normal tissue complication probability (NTCP).  
Materials and Methods: In this study, immobilization and CT 
simulation were performed for 15 prostate cancer patients, as is 
routine for prostate cancer patients receiving IMRT in our department. 
The treatment position is supine with kneefix. Using the simulator 
lasers, patients were aligned and marked to define the coordinate 
system to be used for treatment planning. The patients were scanned 
in treatment position on Siemens Emotion Duo using 5-mm slice 
thickness. The data transferred to the treatment planning system. The 
determination of the 15 prostate cancer patient’s target volume and 
critical tissues are initially done by using CT images obtained in our 
clinic. After definition of the critical organs which are rectum, 
bladder and femoral heads, three different IMRT plans were done for 
each of 15 patients using 6 MV, 15 MV and mixed 6 and 15 MV energies 
using similar dose constraints and 8-fields setting. Gantry angles of 
225o,260o, 295o, 330o, 65o, 100oand 135o are used in our clinic for IMRT 
plans for prostate cancer. For the plan of mixed-energy, 15 MV photon 
beams at the gantry angles of 100oand 260o were used while 6 MV 
were used for the rest of the gantry angles.The dose distributions 
were similar for all plannings. Three plans were evaluated and 
compared by using EUD and NTCP.  
Results: For the bladder, rectum and both right and left femoral 
heads, the NTCP values were calculated less than %1 for the plannings 
with 6 MV, 15 MV and mixed energy plans. However, NTCP values to 
the bladder and rectum of mixed-energy plans were slightly lower 
than that of 6 MV and 15 MV plans. 
Conclusions: The study does not show any significant differences 
between plannings with 6 MV, 15 MV and mixed energies with respect 
to NTCP. Also there is no significant difference in the dose 
distribution. However, the results of this study show that by using 
mixed-energy in aprostate IMRT plan, the bladder and rectum doses 
can be slightly reduced and the plan quality can be improved.  
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Purpose/Objective: Due to the complexity of the IMRT dose 
distributions, a modification in the clinical practice such as contour 
definition or prescription may have a dosimetric impact and has to be 
evaluated. This situation occurs for some clinical trials. This study 
aimed at comparing dose distributions obtained for two groups of 
patients representative of clinical practice and a particular clinical 
trial. 
Materials and Methods: In our clinical practice, cancer prostate 
radiotherapy treatments consist in delivering 76Gy/38 fractions using 
IMRT. The following dosimetric objectives are considered for plan 
validation: PTV (D95%>95%), bladder wall (V65Gy<25%, V40Gy<50%), 
rectal wall (V70Gy<15%, V65Gy<25%, V38Gy<50%), and femoral heads 
(V50Gy<10%, V30Gy<50%). For a clinical trial, a new definition of 
contours and a new prescription were defined. Prescription was 
78Gy/39 fractions with the following dosimetric objectives: CTV 
(D99%>78Gy), PTV (D95%>74.1Gy, D1cc<81.9Gy), bladder and rectal 
walls (D30%<72.8Gy, D50%<54.3Gy), femoral heads (D5%<54.3Gy). 30 
patient treated between 2006 and 2012 were randomly selected from 
our database to create a control group. Mean number of MUs and 
homogeneity index ((D2%-D98%)/D50%) were calculated. For organs at 
risk, organs were delineated according to the clinical practice, and 
dose volume histogram values were reported. For the five first 
patients included in the clinical trial, contours and plans were 
validated following protocol recommendations. However, contours 
were also defined according to the clinical practice. For example, the 
bladder was contoured either only 18mm above the base of the 
prostate and in totality for clinical trial and clinical practice, 
respectively. For these 5 patients, usual dose volume histogram values 
were reported and compared to the control group. 
Results: Homogeneity indices were 0.05±0.01 and 0.10±0.02 for CTV 
and PTV respectively for the control group. They were slightly better 
for the study group: 0.04±0.01 and 0.07±0.01. These results showed a 
satisfactory target volume coverage whatever the protocol. Compared 
to the control group, number of MUs was 8% higher for the study 
group. For the bladder, the dose histogram values were reported as a 
function of the percentage of the overlap between the bladder and 
the PTV. Results obtained for the control group showed a very good 
reproducibility and robustness of IMRT prostate planning procedures. 
Values reported for the study group were similar to the control group 
despite the higher dose prescribed to the target volume. Similar 
results were obtained for rectum and femoral heads. 
Conclusions: This study showed that the clinical trial protocol led to 
dosimetric results similar to those obtained in our clinical practice 
despite the differences in contours and prescriptions. Physicians were 
therefore more confident to include patients in the clinical trial.  
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Purpose/Objective: This study was performedto examine the 
potential role of volumetric modulated arc therapy (VMAT) in 
comparison with intensity modulated radiotherapy (IMRT) for pelvic 
malignancies. 
Materials and Methods: Seven field dynamic IMRT and double arc 
VMAT plans were compared for ten pelvic cancer cases in terms of 
total monitoring units (MU), maximum dose, conformity index, 
uniformity or homogeneity index, integral dose and dose to normal 
structures. All the plans were created in eclipse version10 treatment 
planning system (TPS) and executed in Varian Clinax-iX linear 
accelerator through ARIA10 networking platform. Student’s paired t-
test was performed to compare the results. 
Results: Average conformity index of IMRTplan was 1.5+/1 0.12, but 
the VMAT plans achieved on an average of 1.38±0.04(p-value of 
0.016). Average uniformity index for VMAT plan was 1.05±0.01, but in 
IMRT it was 1.074±0.02 (p-value of 0.006). No significant difference 
was observed in maximum dose between IMRT and VMAT (p-value of 
0.854). The integral dose (p-value of 0.003) and normal tissues dose 
was found less in VMAT plans compared to IMRT plans. The average MU 
needed to deliver the dose of 200 cGy per fraction was 415±33 for 
VMAT plans, while for IMRT plan it was 743±92(p-value of 0.000). 
VMAT plans involve two full rotation of gantry, so that it gives more 
freedom in dose modulation. In VMAT, image guidance improves 
tumour targeting and the fast delivery in less than 2-5 minutes helps 
to minimise the probability of intra fractional movement of target and 
critical organs. The reduction in treatment time gives more comfort 
and less stress to patients. Significant reduction of MU in VMATplans 
compared to IMRT may result in less leakage and scattered radiation 
and low overall peripheral dose.  
Conclusions: The comparative study with VMAT versus IMRT employed 
in pelvic cancers proved, better normal tissues sparing and better 
target coverage by VMATcompared to IMRT technique. 
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Purpose/Objective: To compare the quality of 3D versus 2D planning 
in postmastectomy patients in terms of target volume coverage and 
sparing of organs at risk. 
Materials and Methods: 27 postmastectomy patients, 16 with left and 
11 with right sided breast cancer. Clinical target volume was chest 
wall and supraclavicular fossa ± axilla. PTV1a consisted of chest wall, 
up to skin surface and PTV1b consisted of supraclavicular fossa ± axilla 
plus 1 cm margin; distance from skin surface was 0,5 cm. Deliniated 
organs at risk were both lungs, spinal cord and heart for left sided 
breast cancer. Total dose was 50 Gy in 25 fractions. For each patient 
2 plans were made: 3D and 2D plan. For 3D plan forward IMRT 
planning technique was used. Tangential fields were used for PTV1a 
and AP-PA opposed fields for PTV1b, all with 6MV photons. 2D plan 
was made using direct electron field (energy 9-12 MeV, depending on 
chest wallthickness) on PTV1a and combination of direct electron field 
(18 Mev) and direct photon field (6 MV) on PTV1b. For PTV1a bolus of 
0,5 cm was used. For 3D plans required PTV coverage with 95-107% of 
prescribed dose was at least 85%. Dose constraints for OAR were 
V20Gy< 35% for lung, Dmax <45 Gy for spinal cord and V20Gy< 10% and 
V40Gy< 5% for heart. Patients were placed on Med-Tec MT-350 with 
both hands above head, head in forward position. For planning XIO 
4.3.1 and 4.6.4 with fast-superposition and superposition algorhytm 
respectably for the photon beam calculation were used. Electron 
fields were calculated with pencil beam algorhytm. The CT slice 
thickness and calculation resolution of 0,2 cm was used. 
Statistical method: student t-test. 
Results 
 Coverage 
PTV1a 
(%) 
Coverage 
PTV1b 
(%) 
Dmax (Gy) 
Lung 
L 
V20Gy
(%) 
Lung 
L MD 
(Gy) 
Lung 
R 
V20Gy
(%) 
Lung 
R MD 
(Gy) 
Heart 
V20Gy
(%) 
Heart 
V40Gy
(%) 
Heart 
MD 
(Gy) 
Spinal 
cord 
Dmax (Gy) 
Left 
sided 
           
3D 88.8 
(3.5)* 
90.4 
(3.9) 
53.5 
(0.2) 
31.9 
(6.3) 
16.2 
(2.7) 
0.35 
(0.88) 
0.67 
(0.49)
7.6 
(1.9) 
3.5 
(1.1) 
5.0 
(1.2) 
36. 
(9.6) 
2D 83.1 
(7.2) 
61.2 
(16.2) 
73.5 
(3.3) 
31.0 
(13.3) 
15.2 
(5.4) 
0.85 
(1.39) 
1.98 
(0.98)
5.3 
(3.5) 
0.4 
(0.5) 
5.6 
(1.9) 
33.2 
(6.2) 
p-
value 
<0.01 <10-6 <10-
6 
NS** NS NS <10-4 <0.03 <10-6 NS NS 
Right 
sided 
 
3D 91.2 
(3.2) 
89.5 
(2.0) 
53.6 
(0.2) 
0.06 
(0.1) 
0.4 
(0.1) 
34.2 
(2.0) 
17.0 
(1.3) 
 39.7 
(5.8) 
2D 82.4 
(6.4) 
51.7 
(19.3) 
74.4 
(2.2) 
0.25 
(0.4) 
2.2 
(0.8) 
28.6 
(9.6) 
14.8 
(4.2) 
34.1 
(4.6) 
p-
value 
<0.01 <10-5 <10-
6 
<10-6 NS NS NS <0,03 
 
* median and standard deviation, ** not significant 
Statistically significant difference for left-sided breast cancer was 
observed in PTV1a and PTV1b coverage, MD on right lung, V20Gy and 
V40Gy on heart and Dmax. For right-sided breast cancer statistically 
significant difference was observed in PTV1a and PTV1b coverage, 
V20Gy on left lung, Dmax on spinal cord and Dmax.  
Conclusions: 3D planning provided significantly better PTV coverage 
and lower maximal doses, but without significant influence on doses 
on OAR (lungs and spinal cord) when compared to 2D planning. 
Nevertheless, higher doses on heart were observed with 3D planning, 
but within dose constraints. 
   
EP-1219   
Planning study of locally advanced ethmoid sinus cancer patient. 
H. Tanaka1, K. Nihei1, S. Kitou1, S. Kageyama1, T. Mitsuhashi1, K. 
Karasawa1 
1Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome 
Hospital, Radiation Oncology, Tokyo, Japan  
 
Purpose/Objective: The aim of this study is to compare the dose 
distributions of intensity-modulated radiotherapy (IMRT) plans and 
accuracy of patient setting between MHI TM-2000 (VERO), 
TomoTherapy HiArt System (TomoTherapy), and conventional linac 
(Clinac 21EX), all of which are installed in our institution. 
Materials and Methods: One patient with locally advanced ethmoid 
sinus cancer (T4aN0M0) treated by IMRT at our institution was 
evaluated in this planning study. The clinical target volume (CTV) was 
defined as gross tumor volume and right side nasal and paranasal 
sinus. The planning targetvolume (PTV) was defined as the CTV + 
three-dimensional margins of 5 mm. IMRT planning was implemented 
for 3 different treatment machines, including VERO,TomoTherapy, 
and Clinac 21EX, so as to achieve the similar optimal dose delivery to 
the target volumes with the same dose constraints for normal tissues. 
IMRT schedule consisted of 70Gy in 35fr. As the method of IMRT, 
segmental multi-leaf collimator (MLC) IMRT with 9 static ports, helical 
IMRT, and dynamic MLC IMRT with 9 static ports (2 non-coplaner ports 
and 7 coplaner ports), were adopted for VERO, TomoTherapy, and 
Clinic 21EX, respectively. As planning software, iPlan ver.4.5.1, 
TomoTherapy Planning Station 4.1.2, and Eclipse ver.10.0 were used 
for VERO, TomoTherapy, and Clinac 21EX, respectively. The dose-
volume parameters described below were calculated in each 
treatment machine: D2, D50 and D95 of the PTV and CTV; D2 of the 
optic nerves, chiasm, and eye balls; average dose of the Brain. As 
Modality of image guidance, Cone beam CT (KvCT), Cone beam CT 
(MvCT), and 2D EPID were used for VERO, TomoTherapy, and Clinac 
21EX, respectively. 
Results: The dose-volume parameters calculated in each treatment 
machine are shown in the table. 
 
  
Conclusions: The target volume coverage and the normal tissue doses 
in patients with locally advanced ethmoid sinus cancer were compared 
between the 3 treatment plans, using VERO, TomoTherapy, and Clinac 
21EX. All plans achieved acceptable dose delivery, but plan of Clinac 
21EX with 2D EPID may not achieve enough accuracy of patient 
setting.  
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Purpose/Objective: The beam attenuation impact on the planed dose 
distribution, due to the immobilization and repositioning systems 
(IRSs) used in radiotherapy, was studied to evaluate the need of IRS 
contouring.  
Materials and Methods: Three IRSs were selected for this study. In 
particular an uni-frame with PMMA support (UFP) (Tema Sinergie) was 
tested for 3DCRT 6 MV treatments, an uni-frame with carbon support 
(UFC) (Civco) was tested for head and neck IMTR 6 MV treatments and 
a Body Fix (BF) (3D Line) was tested for stereobody 6 and 15 MV 
treatments. The beam attenuation, when the beam axis intercepts the 
IRSs, was measured for 6 MV and 15 MV photon beams by ion-chamber 
and simulated by Eclipse (Varian) TPS to assess the TPS accuracy in 
modelling the IRS. Then 10 patients for each IRS were selected and 
two treatment plans were performed for each patient, with and 
without IRS contouring. The two plans were compared using dose 
volume histograms (DVH) and in particular evaluating the average 
dose to target variations. A method of transit in-vivo dosimetry (IVD) 
by EPID was adopted to verify that the IRS contouring was performed 
and gave the expected results in clinical routine. 
Results: The percentage of attenuations measured by ion-chamber for 
6 and 15 MV beams were 8.0% and 4.5% for UFP, 5.0% and 3.5% for UFC 
and 3% and 2% for BF respectively. These data were well reproduced 
by the TPS within ±1%. The mean percentage target dose variations 
obtained comparing the IRS contoured and not countered plans and 
averaged over the ten selected patients were 2.9 %, 1.1 % and 1.3 % 
for UFP, UFC and BF respectively. While the maximum percentage 
target dose variations were 6.5 %, 2.8 % and 2.5 % for UFP, UFC and BF 
respectively. IVD for patients with contoured IRS, performed in 
